Research progress on the relationship between cerebral small vessel disease and insulin resistance

doi:10.20039/j.cnki.10073949.2024.06.013.

Home > Archive>Volume 32, Issue 6, 2024 >547-552. DOI:10.20039/j.cnki.10073949.2024.06.013.

Research progress on the relationship between cerebral small vessel disease and insulin resistance
DOI:
                        10.20039/j.cnki.10073949.2024.06.013.
                    
CSTR:
                        
                    
Author:
                        WANG LeiWANG Lei
1.Graduate School of Xinxiang Medical College, Xinxiang, Henan 453000, China;2.Department of Neurology, Nanyang Central Hospital, Nanyang, Henan 473000, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site
ZHANG BaochaoZHANG Baochao
1.Graduate School of Xinxiang Medical College, Xinxiang, Henan 453000, China;2.Department of Neurology, Nanyang Central Hospital, Nanyang, Henan 473000, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site

                    
Affiliation:1.Graduate School of Xinxiang Medical College, Xinxiang, Henan 453000, China;2.Department of Neurology, Nanyang Central Hospital, Nanyang, Henan 473000, China)
Clc Number:R743.3
Fund Project:

Article

Figures

Metrics

Reference [48]

Cited by

Materials

Comments

Abstract:

Cerebral small vessel disease (CSVD) refers to a series of clinical imaging pathological syndromes caused by various etiologies affecting cerebral small vessels, which have the characteristics of insidious onset, high incidence and easy recurrence. Insulin resistance (IR) is a decrease in the body's sensitivity to insulin. In recent years, more and more studies have confirmed that IR is associated with the occurrence and development of imaging features of CSVD, but the mechanism is still unclear. This article reviews the relationship between IR and cerebral small vessel disease and its possible mechanism, in order to provide reference for the prevention and treatment of cerebral small vessel disease.

Key words:cerebral small vessel disease; insulin resistance; neuroimaging; endothelial dysfunction; atherosclerosis; inflammation

Reference

[1] HAFFNER C, MALIK R, DICHGANS M.Genetic factors in cerebral small vessel disease and their impact on stroke and dementia.J Cereb Blood Flow Metab, 6,6(1):158-171.

[2] 徐运.脑小血管病的诊疗现状和研究新进展.中风与神经疾病杂志, 3,0(4):291-296.XU Y.Current status and research progress in the diagnosis and treatment of cerebral small vessel disease.Journal of Apoplexy and Nervous Diseases, 3,0(4):291-296.

[3] CHEN X M, WANG L, JIANG J Y, et al.Association of neuroimaging markers of cerebral small vessel disease with short-term outcomes in patients with minor cerebrovascular events.BMC Neurol, 1,1(1):21.

[4] WATROBA M, GRABOWSKA A D, SZUKIEWICZ D.Effects of diabetes mellitus-related dysglycemia on the functions of blood-brain barrier and the risk of dementia.Int J Mol Sci, 3,4(12):10069.

[5] LEE D Y, LEE E S, KIM J H, et al.Predictive value of triglyceride glucose index for the risk of incident diabetes:a 4-year retrospective longitudinal study.PLoS One, 6,1(9):e0163465.

[6] SON D H, LEE H S, LEE Y J, et al.Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome.Nutr Metab Cardiovasc Dis, 2,2(3):596-604.

[7] LUO P, CAO Y Q, LI P Z, et al.TyG index performs better than HOMA-IR in chinese type 2 diabetes mellitus with a BMI ＜35 kg/m²:a hyperglycemic clamp validated study.Medicina (Kaunas), 2,8(7):876.

[8] MARKUS H S, DE LEEUW F E.Cerebral small vessel disease:recent advances and future directions.Int J Stroke, 3,8(1):4-14.

[9] LEE J E, SHIN D W, YUN J M, et al.Insulin resistance is a risk factor for silent lacunar infarction.Stroke, 6,7(12):2938-2944.

[10] DEARBORN J L, SCHNEIDER A L C, SHARRETT A R, et al.Obesity, insulin resistance, and incident small vessel disease on magnetic resonance imaging:atherosclerosis risk in communities study.Stroke, 5,6(11):3131-3136.

[11] YANG X L, ZHANG S F, DONG Z Y, et al.Insulin resistance is a risk factor for overall cerebral small vessel disease burden in old nondiabetic healthy adult population.Front Aging Neurosci, 9,1:127.

[12] JUNG D H, PARK B, LEE Y J.Relationship of the triglyceride-glucose index with subclinical white matter hypersensitivities of presumed vascular origin among community-dwelling koreans.Int J Gen Med, 2,5:603-608.

[13] NAM K W, KWON H M, JEONG H Y, et al.High triglyceride-glucose index is associated with subclinical cerebral small vessel disease in a healthy population:a cross-sectional study.Cardiovasc Diabetol, 0,9(1):53.

[14] WEINSTEIN G, MAILLARD P, HIMALI J J, et al.Glucose indices are associated with cognitive and structural brain measures in young adults.Neurology, 5,4(23):2329-2337.

[15] NOUWEN A, CHAMBERS A, CHECHLACZ M, et al.Microstructural abnormalities in white and gray matter in obese adolescents with and without type 2 diabetes.Neuroimage Clin, 7,6:43-51.

[16] HAWKINS K A, EMADI N, PEARLSON G D, et al.Hyperinsulinemia and elevated systolic blood pressure independently predict white matter hyperintensities with associated cognitive decrement in the middle-aged offspring of dementia patients.Metab Brain Dis, 7,2(3):849-857.

[17] HJORTEBJERG R, LAUGESEN E, HYEM P, et al.The IGF system in patients with type 2 diabetes:associations with markers of cardiovascular target organ damage.Eur J Endocrinol, 7,6(5):521-531.

[18] 蔡雅真.甘油三酯葡萄糖指数与非糖尿病患者脑部扩大的血管周围间隙的相关性研究.福州:福建医科大学, 2021:1-54.CAI Y Z.Association between triglyceride-glucose index and enlarged perivascular spaces in non-diabetic patients.Fuzhou:Fujian Medical University, 2021:1-54.

[19] ARBA F, QUINN T J, HANKEY G J, et al.Enlarged perivascular spaces and cognitive impairment after stroke and transient ischemic attack.Int J Stroke, 8,3(1):47-56.

[20] WU D H, YANG X L, ZHONG P, et al.Insulin resistance is independently associated with enlarged perivascular space in the basal ganglia in nondiabetic healthy elderly population.Am J Alzheimers Dis Other Demen, 0,5:1533317520912126.

[21] CAI Y, CHEN B, ZENG X, et al.The triglyceride glucose index is a risk factor for enlarged perivascular space.Front Neurol, 2,3:782-786.

[22] CHEN X D, WANG J H, SHAN Y L, et al.Cerebral small vessel disease:neuroimaging markers and clinical implication.J Neurol, 9,6(10):2347-2362.

[23] HAJI S, PLANCHARD R, ZUBAIR A, et al.The clinical relevance of cerebral microbleeds in patients with cerebral ischemia and atrial fibrillation.J Neurol, 6,3(2):238-244.

[24] LI D, LI Y, WANG T L, et al.Correlation between insulin resistance and cerebral microbleeds among chinese patients with cerebral small vessel disease.J Clin Neurosci, 3,1:1-5.

[25] ZHANG J Y, HU M, JIA Y Q, et al.The triglyceride glucose index is associated with the cerebral small vessel disease in a memory clinic population.J Clin Neurosci, 2,4:126-133.

[26] 胡文立, 杨磊, 李譞婷, 等.中国脑小血管病诊治专家共识2021.中国卒中杂志, 1,6(7):716-726.HU W L, YANG L, LI X T, et al.Chinese consensus on diagnosis and therapy of cerebral small vessel disease 2021.Chinese Journal of Stroke, 1,6(7):716-726.

[27] TENG Z J, FENG J, DONG Y H, et al.Triglyceride glucose index is associated with cerebral small vessel disease burden and cognitive impairment in elderly patients with type 2 diabetes mellitus.Front Endocrinol (Lausanne), 2,3:970122.

[28] WARDLAW J M, SMITH C, DICHGANS M.Mechanisms of sporadic cerebral small vessel disease:insights from neuroimaging.Lancet Neurol, 3,2(5):483-497.

[29] WANG X, CHAPPELL F M, VALDES HERNANDEZ M, et al.Endothelial function, inflammation, thrombosis, and basal ganglia perivascular spaces in patients with stroke.J Stroke Cerebrovasc Dis, 6,5(12):2925-2931.

[30] TROILI F, CIPOLLINI V, MOCI M, et al.The anatomical crossroad between the immune, vascular and nervous system.Front Neuroanat, 0,4:17-34.

[31] MUNIYAPPA R, CHEN H, MONTAGNANI M, et al.Endothelial dysfunction due to selective insulin resistance in vascular endothelium:insights from mechanistic modeling.Am J Physiol Endocrinol Metab, 0,9(3):E629-E646.

[32] YAMAMOTO M, GUO D H, HERNANDEZ C M, et al.Endothelial adora2a activation promotes blood-brain barrier breakdown and cognitive impairment in mice with diet-induced insulin resistance.J Neurosci, 9,9(21):4179-4192.

[33] OGATA S, ITO S, MASUDA T, et al.Changes of blood-brain barrier and brain parenchymal protein expression levels of mice under different insulin-resistance conditions induced by high-fat diet.Pharm Res, 9,6(10):141.

[34] TANAKA M S I.Improving obesity and blood pressure.Hypertension Research, 0,3(2):79-89.

[35] METZ M, O'HARE J, CHENG B, et al.Brain insulin signaling suppresses lipolysis in the absence of peripheral insulin receptors and requires the MAPK pathway.Mol Metab, 3,3:101723.

[36] WARDLAW J M, WOODHOUSE L J, MHLANGA I I, et al.Isosorbide mononitrate and cilostazol treatment in patients with symptomatic cerebral small vessel disease:the lacunar intervention trial-2 (LACI-2) randomized clinical trial.JAMA Neurol, 3,0(7):682-692.

[37] ALTENDAHL M, MAILLARD P, HARVEY D, et al.An IL-18-centered inflammatory network as a biomarker for cerebral white matter injury.PLoS One, 0,5(1):e0227835.

[38] RASMUSSEN M K, MESTRE H, NEDERGAARD M.The glymphatic pathway in neurological disorders.Lancet Neurol, 8,7(11):1016-1024.

[39] PETERSEN M A, RYU J K, AKASSOGLOU K.Fibrinogen in neurological diseases:mechanisms, imaging and therapeutics.Nat Rev Neurosci, 8,9(5):283-301.

[40] HANSSON G K.Inflammation and atherosclerosis:the end of a controversy.Circulation, 7,6(20):1875-1877.

[41] WISEMAN S, MARLBOROUGH F, DOUBAL F, et al.Blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-lacunar stroke and non-stroke:systematic review and meta-analysis.Cerebrovasc Dis, 4,7(1):64-75.

[42] SHI W R, XING L Y, JING L, et al.Value of triglyceride-glucose index for the estimation of ischemic stroke risk:insights from a general population.Nutrition Metabolism and Cardiovascular Diseases, 0,0(2):245-253.

[43] MAO Q, ZHOU D L, LI Y M, et al.The triglyceride-glucose index predicts coronary artery disease severity and cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome.Dis Markers, 9,9:6891537.

[44] JIANG X, ANDJELKOVIC AV, ZHU L, et al.Blood-brain barrier dysfunction and recovery after ischemic stroke.Prog Neurobiol, 8,3-164:144-171.

[45] SHI Y L, WARDLAW J M.Update on cerebral small vessel disease:a dynamic whole-brain disease.Stroke Vasc Neurol, 6,1(3):83-92.

[46] HOSCHEIDT S M, KELLAWAN J M, BERMAN S E, et al.Insulin resistance is associated with lower arterial blood flow and reduced cortical perfusion in cognitively asymptomatic middle-aged adults.J Cereb Blood Flow Metab, 7,7(6):2249-2261.

[47] WANG Y Q, SUN L, HE G Y, et al.Cerebral perfusion alterations in type 2 diabetes mellitus-a systematic review.Front Neuroendocrinol, 1,2:100916.

[48] HILL M A, YANG Y, ZHANG L P, et al.Insulin resistance, cardiovascular stiffening and cardiovascular disease.Metabolism, 1,9:154766.

Get Citation

WANG Lei, ZHANG Baochao. Research progress on the relationship between cerebral small vessel disease and insulin resistance[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2024,32(6):547-552.

Copy

Article Metrics

Abstract:91
PDF: 451
HTML: 0
Cited by: 0

History

Received:June 28,2023
Revised:August 12,2023
Adopted:
Online: July 04,2024
Published:

Policies & Instructions

Get Citation

Share

Article Metrics

History

Article QR Code